Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BUTYLIN SYRUP 1.5 mg/5 ml

Approval Number

SIN08075P

Drug Name

BUTYLIN SYRUP 1.5 mg/5 ml

Product Name

BUTYLIN SYRUP 1.5 mg/5 ml

Approval Date

March 18, 1995

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R03CC03

ATC Item Name

terbutaline

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

HOVID BHD

Active Ingredients

Ingredient Name

TERBUTALINE SULPHATE

Strength

1.5 mg/5 ml

Drug MonographTerbutaline

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy